COMPASS Pathways(CMPS) - 2023 Q2 - Quarterly Report

• an increase of $0.8 million in non-cash share-based compensation expense due to increased staffing levels year over year and equity awards granted to our chief executive officer in August 2022; and During the six months ended June 30, 2023 and 2022, we recognized an R&D tax credit in the UK as a benefit within other income, net of $6.4 million and $7.0 million, respectively. The tax credit receivable decreased by $0.6 million in 2023 compared to 2022 due to a reduction in the R&D tax relief rates. Up unti ...